Recently, the global pharmaceutical industry event CPHI was grandly held in Shanghai. Unilong Industry showcased a variety of innovative products and cutting-edge solutions, presenting its profound strength and innovative achievements in the pharmaceutical field in an all-round way. It attracted extensive attention from numerous domestic and foreign customers, industry experts and media.
At this exhibition, Unilong’s booth stood out as a major highlight with its unique design and rich display content. The booth has been meticulously planned with a product display area, a technical exchange area and a negotiation area, creating a professional and comfortable communication environment. In the product display area, the company showcased its core products covering multiple fields such as pharmaceutical raw materials and high-end formulation products. Among them, the newly developed PVP and sodium hyaluronate, with their breakthrough technology and outstanding performance, became the focus of the entire event. This product effectively addresses applications in various fields. Compared with traditional products, it has a significant advantage in molecular weight, attracting many customers to stop and inquire.
During the exhibition, Unilong received over a hundred customers from many countries and regions around the world. The company’s professional sales and technical teams had in-depth exchanges with the customers. They not only detailed the features and advantages of the products but also provided customized solutions based on the customers’ individualized demands. Through face-to-face communication, the client’s understanding and trust in the company’s products and services were further deepened, and multiple cooperation intentions were reached on the spot. Meanwhile, company representatives also actively participated in various forums and seminars held at the exhibition, discussing the development trends and cutting-edge technologies of the pharmaceutical industry with industry experts and peer enterprises, sharing the company’s innovative experiences and practical achievements, and further enhancing the company’s reputation and influence within the industry.
Our main products are as follows:
Product Name | CAS No. |
Polycaprolactone PCL | 24980-41-4 |
Polyglyceryl-4 Oleate | 71012-10-7 |
Polyglyceryl-4 Laurate | 75798-42-4 |
Cocoyl Chloride | 68187-89-3 |
1,1,1,3,3,3-Hexafluoro-2-Propanol | 920-66-1 |
Carbomer 980 | 9007-20-9 |
Titanium Oxysulfate | 123334-00-9 |
1-Decanol | 112-30-1 |
2,5-Dimethoxybenzaldehyde | 93-02-7 |
3,4,5-Trimethoxybenzaldehyde | 86-81-7 |
1,3-Bis(4,5-dihydro-2-oxazolyl)benzene | 34052-90-9 |
Laurylamine Dipropylene Diamine | 2372-82-9 |
Polyglycerin-10 | 9041-07-0 |
Glycyrrhizic Acid Ammonium Salt | 53956-04-0 |
Octyl 4-methoxycinnamate | 5466-77-3 |
Arabinogalactan | 9036-66-2 |
Sodium Stannate Trihydrate | 12209-98-2 |
SMA | 9011-13-6 |
2-hydroxypropyl-β-cyclodextrin | 128446-35-5/94035-02-6 |
DMP-30 | 90-72-2 |
ZPT | 13463-41-7 |
Sodium Hyaluronate | 9067-32-7 |
Glyoxylic Acid | 298-12-4 |
Glycolic Acid | 79-14-1 |
Aminomethyl Propanediol | 115-69-5 |
Polyethyleneimine | 9002-98-6 |
Tetrabutyl Titanate | 5593-70-4 |
Nonivamide | 2444-46-4 |
Ammonium Lauryl Sulphate | 2235-54-3 |
Glycylglycine | 556-50-3 |
N,N-Dimethylpropionamide | 758-96-3 |
Polystyrene Sulfonic Acid/Pssa | 28210-41-5 |
Isopropyl Myristate | 110-27-0 |
Methyl Eugenol | 93-15-2 |
10,10-Oxybisphenoxarsine | 58-36-6 |
Sodium Monofluorophosphate | 10163-15-2 |
Sodium Isethionate | 1562-00-1 |
Sodium Thiosulfate Pentahydrate | 10102-17-7 |
Dibromomethane | 74-95-3 |
Polyethylene Glycol | 25322-68-3 |
Cetyl Palmitate | 540-10-3 |
Participating in the CPHI exhibition this time is an important step for Unilong to expand its global market. Through the exhibition platform, we not only showcased our company’s innovative strength and high-quality products to global customers, but also gained valuable market feedback and cooperation opportunities. A relevant person in charge of Unilong stated, “In the future, the company will continue to adhere to the innovation-driven development strategy, increase investment in research and development, and constantly launch more high-quality and high-performance products and solutions to contribute to the development of the global pharmaceutical industry.”
As an important communication platform for the global pharmaceutical industry, CPHI exhibition gathers industry elites and high-quality resources from all over the world. Unilong’s outstanding performance at this exhibition not only highlights the company’s leading position in the pharmaceutical field but also lays a solid foundation for the company to further expand its international market. Looking ahead, Unilong will take this exhibition as an opportunity to continuously deepen cooperation with global customers and join hands to create a bright future for the pharmaceutical industry.
Post time: Jul-03-2025